CN103815223A - 一种含虾青素的营养保健组合物 - Google Patents
一种含虾青素的营养保健组合物 Download PDFInfo
- Publication number
- CN103815223A CN103815223A CN201410030943.9A CN201410030943A CN103815223A CN 103815223 A CN103815223 A CN 103815223A CN 201410030943 A CN201410030943 A CN 201410030943A CN 103815223 A CN103815223 A CN 103815223A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- care composition
- health care
- fos
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 44
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 44
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 44
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 44
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 235000016709 nutrition Nutrition 0.000 title abstract description 6
- 230000035764 nutrition Effects 0.000 title abstract description 6
- 230000036541 health Effects 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 19
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 14
- 239000012138 yeast extract Substances 0.000 claims abstract description 14
- 239000003826 tablet Substances 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000008187 granular material Substances 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 20
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000011122 softwood Substances 0.000 claims description 5
- 235000020985 whole grains Nutrition 0.000 claims description 5
- 239000000470 constituent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 241000081271 Phaffia rhodozyma Species 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 241000186000 Bifidobacterium Species 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 abstract description 2
- 229940107187 fructooligosaccharide Drugs 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- 235000021466 carotenoid Nutrition 0.000 description 5
- 150000001747 carotenoids Chemical class 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 3
- 229920002774 Maltodextrin Polymers 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940035034 maltodextrin Drugs 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000003026 anti-oxygenic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- RASZIXQTZOARSV-BDPUVYQTSA-N astacin Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-BDPUVYQTSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 150000002584 ketoses Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 102000034498 Astacin Human genes 0.000 description 1
- 108090000658 Astacin Proteins 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 235000003676 astacin Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公布了一种含虾青素的营养保健组合物，包含虾青素、低聚果糖粉、酵母抽提物和辅料，其特征在于：所述虾青素的含量为0.05-0.1wt％，低聚果糖粉为20-40wt％，酵母抽提物为0.5-5wt％，辅料为60-80wt％。本发明组合物制备成片剂、丸剂、胶囊剂或颗粒剂。本发明具有抗氧化、抗肿瘤和增强免疫力，调节肠道菌群，增殖双歧杆菌，促进钙的吸收，调节血脂，免疫调节，抗龋齿等保健功能。专注于人类营养与保健，促进人类健康。
Description
技术领域
本发明涉及营养食品的制备，特别是一种含虾青素的营养保健组合物。
技术背景
虾青素是一种氧化型的类胡萝卜素，化学名称为3，3’-二羟基-4，4’-二酮基-β，β’-胡萝卜素，分子式C40H52O4，分子量596.86，是一种萜烯类不饱和化合物，呈粉红色，是600多种类胡萝卜素中的一种。
虾青素(astaxanthin／astacin／astacean)是自然界水生动物体中主要的类胡萝卜素成分，对水生生物的生命活动有重要的意义。同大多数动物一样，人类不能在体内合成类胡萝卜素类物质，也只能通过食品摄入而获得，如水产品，如虾、蟹和某些冷水鱼类中就含有虾青素，成为人们补充类胡萝卜素的动物性来源。虾青素是一种氧化态的胡萝卜素，研究表明虾青素的抗氧化能力是维生素E的500倍，是胡萝卜素的11倍以上，具有明显的抗氧化、消除活性的单线态氧的作用。动物实验表明虾青素有增强免疫功能、抗肿瘤、抗紫外辐射，可以抑 制老年斑的形成，对眼科疾病、心血管疾病和类风湿性关节炎也有缓解作用；据最新研究，虾青素对视觉疲劳具有明显的改善作用，对作息时间紊乱的人群恢复正常的生活节奏也有一定的帮助作用。所以，虾青素具有重要的营养和保健作用。但虾青素与维生素一样不能被人体合成，只能从食物中摄取。
低聚果糖(fructooligsacchride，FOS，以下称FOS)又名蔗果低聚糖，寡果糖或蔗果三糖族低聚糖，分子式为G-F-Fn(n＝1，2，3，G为葡萄糖，F为果糖)，它是由蔗糖和1～3个果糖基通过β-1，2糖苷键与蔗糖中的果糖基结合而成的蔗果三糖(GF2)，蔗果四糖(GF3)和蔗果五糖(GF4)等一类碳水化合物总称。
低聚果糖粉是一种天然活性物质。甜度为蔗糖的0.3倍。既保持了蔗糖的纯正甜味性质，又比蔗糖甜味清爽。低聚果糖只能被双歧杆菌和乳酸菌所利用，不能被肠道其它细菌所利用，它在人体消化道内不会被胃酸、胆汁和各种消化酶分解而吸收，可直达大肠中被嗜酸性乳酸杆菌、双歧杆菌等有益菌选择利用，使他们快速并大量繁殖，是双岐杆菌增殖因子。这些益生菌对低聚果糖进行酵解后，从而发挥一系列生理学功能。低聚果糖具有调节肠道菌群，增殖双歧杆菌，促进钙的吸收，调节血脂，免疫调节，抗龋齿等保健功能的新型甜味剂，被誉为继抗生素时代后最具潜力的新一代添加剂——促生物质。
发明内容
本发明的目的在于提供一种含虾青素的营养保健组合物，加入虾青素与低聚果糖粉后，改善人类的综合体质，专注于人类营养与保健， 促进人类健康。
一种含虾青素的营养保健组合物，包含虾青素、低聚果糖粉、酵母抽提物和辅料，其特征在于：所述虾青素的含量为0.05-0.1wt％，低聚果糖粉为20-40wt％，酵母抽提物为0.5-5wt％，辅料为60-80wt％。
进一步地，所述各组分含量优选为：
虾青素0.02-0.08wt％
低聚果糖粉20-30wt％
酵母抽提物1-5wt％
辅料65-80wt％。
进一步地，所述各组分含量优选为：
虾青素0.05-0.08wt％
低聚果糖粉25-30wt％
酵母抽提物2-4wt％
辅料66-73wt％。
进一步地，所述虾青素是由红法夫酵母采用液体深层发酵法发酵提取的天然虾青素。
所述低聚果糖粉为低聚果糖总含量≥95％的低聚果糖粉。
所述辅料是赋形剂，为调整口味而添加的调味剂，为增加其他方面的营养而添加的其他辅料等，可以根据需要加入。
本发明组合物可依据本领域的常规工艺制备为适于食用的各种剂型，如片剂、丸剂、胶囊剂、颗粒剂等。
进一步优选地，本发明组合物制备为片剂。
进一步地，所述片剂的制备方法包括如下步骤：
1)按比例取低聚果糖粉、酵母抽提物及辅料混匀；
2)加入虾青素混匀后，加入赋形剂，得到软材；
3)利用挤压制粒法得到制湿颗粒，立即在50～80℃温度下烘干，整粒后压片(每片重0.5g)，制好后包装即可。
本发明组合物中，虾青素作为抗氧化剂的服用量每日最少3mg，长期持续作为抗疲劳需要8-10mg/日，2个月有效，作为降血脂用途需要10-12mg/日，一般情况下2-4周会有较明显的反应。本片剂每粒质量0.5g，普通保健食用，建议每天1-2粒即可，其他情况，适量食用。
本发明与现有技术相比，具有如下优点：
1、本发明制备的营养保健片剂具有抗氧化、抗肿瘤和增强免疫力等许多重要的生理和生物学功能，其中虾青素的抗氧化性能比维生素E强100-500倍，比胡萝卜素强10倍以上，是目前类胡萝卜素中抗氧化性能最强的色素。对眼科疾病、心血管疾病和类风湿性关节炎有显著的缓解作用。
2、本发明另一成分95低聚果糖粉，是一种天然活性物质。甜度为蔗糖的0.3倍。既保持了蔗糖的纯正甜味性质，又比蔗糖甜味清爽。且在粘度等方面性能优良，从而取代了蔗糖在片剂中的添加。而且低聚果糖是具有调节肠道菌群，增殖双歧杆菌，促进钙的吸收，调节血脂，免疫调节，抗龋齿等保健功能的新型甜味剂，被誉为继抗生素时代后最具潜力的新一代添加剂——促生物质。
附图说明
图1为本发明工艺流程图。
具体实施方式
实施例1
将适量麦芽糊精(辅料)、63g低聚果糖粉、2.5g酵母抽提物混匀后，加入2.5g虾青素混匀，加入赋形剂，得到软材，利用挤压制粒法得到制湿颗粒，立即在50～80℃温度下烘干，整粒后压片500片(每片重0.5g)，制好后包装即可。
服用方法：每天1-2粒。
实施例2
将适量麦芽糊精(辅料)、64g低聚果糖粉、5g酵母抽提物混匀后，加入2g虾青素混匀，加入赋形剂，得到软材，利用挤压制粒法得到制湿颗粒，立即在50～80℃温度下烘干，整粒后压片500片(每片重0.5g)，制好后包装即可。
服用方法：每天1-2粒。
实施例3
将适量麦芽糊精(辅料)、65g低聚果糖粉、10g酵母抽提物混匀后，加入1.5g虾青素混匀，加入赋形剂，得到软材，利用挤压制粒法得到制湿颗粒，立即在50～80℃温度下烘干，整粒后压片500片(每片重0.5g)，制好后包装即可。
服用方法：每天1-2粒。
Claims (7)
1.一种含虾青素的营养保健组合物，包含虾青素、低聚果糖粉、酵母抽提物和辅料，其特征在于：所述虾青素的含量为0.05-0.1wt％，低聚果糖粉为20-40wt％，酵母抽提物为0.5-5wt％，辅料为60-80wt％。
2.根据权利要求1所述的一种含虾青素的营养保健组合物，其特征在于：所述虾青素是由红法夫酵母采用液体深层发酵法发酵提取的天然虾青素；所述低聚果糖粉为低聚果糖总含量≥95％的低聚果糖粉。
3.根据权利要求2所述的一种含虾青素的营养保健组合物，其特征在于所述各组分含量为：
虾青素0.03-0.08wt％
低聚果糖粉20-30wt％
酵母抽提物1-5wt％
辅料65-80wt％。
4.根据权利要求3所述的一种含虾青素的营养保健组合物，其特征在于所述各组分含量为：
虾青素0.05-0.08wt％
低聚果糖粉25-30wt％
酵母抽提物2-4wt％
辅料66-73wt％。
5.根据权利要求3或4所述的一种含虾青素的营养保健组合物，其特征在于：所述营养保健组合物制为片剂、丸剂、胶囊剂或颗粒剂。
6.根据权利要求5所述的一种含虾青素的营养保健组合物，其特征在于：所述营养保健组合物制为片剂。
7.根据权利要求6所述的一种含虾青素的营养保健组合物，其特征在于制备为片剂时包括如下步骤：
1)按比例取低聚果糖粉、酵母抽提物及辅料混匀；
2)加入虾青素混匀后，加入赋形剂，得到软材；
3)利用挤压制粒法得到制湿颗粒，立即在50～80℃温度下烘干，整粒后压片，每片重0.5g，制好后包装即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410030943.9A CN103815223A (zh) | 2014-01-23 | 2014-01-23 | 一种含虾青素的营养保健组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410030943.9A CN103815223A (zh) | 2014-01-23 | 2014-01-23 | 一种含虾青素的营养保健组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103815223A true CN103815223A (zh) | 2014-05-28 |
Family
ID=50750752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410030943.9A Pending CN103815223A (zh) | 2014-01-23 | 2014-01-23 | 一种含虾青素的营养保健组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103815223A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014208511A1 (ja) * | 2013-06-27 | 2014-12-31 | 学校法人同志社 | アスタキサンチン含有腸内フローラ改善組成物 |
| CN104905271A (zh) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | 一种具有调节血脂功效的虾青素保健胶囊 |
| CN105434319A (zh) * | 2015-12-07 | 2016-03-30 | 华南理工大学 | 一种基于红发夫酵母原料的化妆品及其制备方法 |
| CN105639655A (zh) * | 2016-02-26 | 2016-06-08 | 暨南大学 | 一种促进肠道双歧杆菌增殖的保健品及应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1748573A (zh) * | 2005-10-10 | 2006-03-22 | 华南理工大学 | 含虾青素营养食品及其制备方法 |
| CN101584485A (zh) * | 2009-06-09 | 2009-11-25 | 宁波大学 | 一种红球藻、菊薯的食品及其制备方法 |
| CN101886108A (zh) * | 2010-06-30 | 2010-11-17 | 集美大学 | 虾青素与低聚果糖联产发酵方法 |
-
2014
- 2014-01-23 CN CN201410030943.9A patent/CN103815223A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1748573A (zh) * | 2005-10-10 | 2006-03-22 | 华南理工大学 | 含虾青素营养食品及其制备方法 |
| CN101584485A (zh) * | 2009-06-09 | 2009-11-25 | 宁波大学 | 一种红球藻、菊薯的食品及其制备方法 |
| CN101886108A (zh) * | 2010-06-30 | 2010-11-17 | 集美大学 | 虾青素与低聚果糖联产发酵方法 |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014208511A1 (ja) * | 2013-06-27 | 2014-12-31 | 学校法人同志社 | アスタキサンチン含有腸内フローラ改善組成物 |
| EP3040069A4 (en) * | 2013-06-27 | 2017-04-12 | The Doshisha | Intestinal flora improving composition containing astaxanthin |
| CN104905271A (zh) * | 2015-06-19 | 2015-09-16 | 青岛浩大海洋保健食品有限公司 | 一种具有调节血脂功效的虾青素保健胶囊 |
| CN105434319A (zh) * | 2015-12-07 | 2016-03-30 | 华南理工大学 | 一种基于红发夫酵母原料的化妆品及其制备方法 |
| CN105434319B (zh) * | 2015-12-07 | 2018-09-14 | 华南理工大学 | 一种基于红发夫酵母原料的化妆品及其制备方法 |
| CN105639655A (zh) * | 2016-02-26 | 2016-06-08 | 暨南大学 | 一种促进肠道双歧杆菌增殖的保健品及应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101496575B (zh) | 一种含短肽和益生菌的特殊营养食品配方 | |
| CN103404921B (zh) | 一种果蔬酵素组合物及其制备方法 | |
| CN101223999B (zh) | 一种全面补充各种人体所需的营养素组合物 | |
| KR101110983B1 (ko) | 미네랄 흡수 촉진제 및 그 용도 | |
| CN103976116A (zh) | 一种磷脂压片糖果及其制备方法 | |
| CN109430407A (zh) | 益生菌组合制剂 | |
| CN103371318B (zh) | 一种膳食营养补充食品 | |
| CN101049150A (zh) | 有广泛用途的食用营养保健钾盐 | |
| CN103815223A (zh) | 一种含虾青素的营养保健组合物 | |
| JP2007223914A (ja) | 経口投与組成物 | |
| CN105192708A (zh) | 天然植物营养强化系列食品 | |
| CN106616956A (zh) | 一种果冻型酵素及其加工工艺 | |
| CN111972589A (zh) | 一种补充维生素a的盐藻粉泡腾片 | |
| CN103271353B (zh) | 一种护肝保健组合物及其制备方法 | |
| JP2008237058A (ja) | 栄養補助食品 | |
| CN103040068A (zh) | 一种石榴固体饮料及其制备方法 | |
| US20060210606A1 (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
| CN102077943A (zh) | 一种记忆力衰退者专用的海洋特膳食品 | |
| CN107136490A (zh) | 一种肽虫草保健品 | |
| JP7216260B2 (ja) | コプロコッカス属菌の増殖促進用組成物 | |
| RU2609874C1 (ru) | Безалкогольный напиток "Комплит Амино Ликвид" | |
| CN101474304A (zh) | 用于降低血糖与血脂的药物组合物 | |
| CN109645312A (zh) | 一种具有食疗保健效果的羽衣甘蓝面粉及其制备方法 | |
| CN103461666A (zh) | 一种具有调节胃肠功能的宠物功能食品配方及其制备方法 | |
| CN109744357A (zh) | 一种对人体肠道有保健功能的糖及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 251200 Shandong province Dezhou Dexin Street (Yucheng) National hi tech Industrial Development Zone Applicant after: Shandong Bailong Park biological Polytron Technologies Inc Address before: Dickson street 251200 Shandong city of Dezhou province Yucheng city high tech Development Zone Applicant before: Shandong Bailong Chuangyuan Biotechnology Co.,Ltd. |
|
| COR | Change of bibliographic data | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140528 |